William Peffley
Family Medicine · Dallas, ORNPI 1275548562
Payments from drug & device makers
Across 130 payments — averaging $24.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$320
- Novo Nordisk$297
- Otsuka America Pharmaceutical, Inc.$262
- Pfizer$240
- E.r. Squibb & Sons, L.L.C.$220
- Johnson & Johnson$206
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,17799%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $320 |
| Novo Nordisk | 14 | $297 |
| Otsuka America Pharmaceutical, Inc. | 8 | $262 |
| Pfizer | 12 | $240 |
| E.r. Squibb & Sons, L.L.C. | 9 | $220 |
| Johnson & Johnson | 11 | $206 |
| Amgen | 8 | $192 |
| Lilly USA, LLC | 2 | $145 |
| Bayer | 7 | $127 |
| Exact Sciences | 5 | $124 |
| Boston Scientific | 2 | $113 |
| Medtronic(2 entities) | 3 | $100 |
| GSK | 5 | $90 |
| Biogen | 1 | $87 |
| Sanofi-aventis U.S. LLC | 4 | $71 |
| Si-bone, Inc. | 1 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| AstraZeneca | 3 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $53 |
| Edwards Lifesciences | 2 | $52 |
| Astellas Pharma US Inc | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Gilead | 1 | $22 |
| Novartis | 1 | $21 |
| Medline Industries LP | 1 | $18 |
| Electromed, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Linus Health, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,212 in reported general payments places this provider in the 90th percentile of 1,221 family medicine providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 24 | $27,344 |
| EliquisApixaban | 22 | $14,956 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,227 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $2,817 |
| Atorvastatin Calcium | 194 | $2,760 |
| Baclofen | 53 | $2,217 |
| Gabapentin | 43 | $1,589 |
| Levothyroxine Sodium | 124 | $1,414 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $1,207 |
| Losartan Potassium | 104 | $1,139 |
| Citalopram HbrCitalopram Hydrobromide | 56 | $1,077 |
| Rosuvastatin Calcium | 54 | $1,054 |
| Bupropion XlBupropion Hcl | 31 | $1,037 |
| Lisinopril | 86 | $1,032 |
| Omeprazole | 56 | $1,008 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $54 | $27,34424 claims |
| PfizerEliquis | $240 | $14,95622 claims |
| GSKTrelegy Ellipta | $90 | $9,22714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,221 family medicine providers in Oregon.
Other family medicine in Dallas
- John DelgadoAshland$4.3M
- John MickelsonLincoln City$2.1M
- Subramaniam SeetharamanMilwaukie$1.8M
- Eden MillerBend$1.7M
- Maureen MaysPortland$491K
- Thomas TurkRoseburg$434K
- Anil RajaniHood River$325K
- Patricia BuchananEugene$239K
- Keith KlattAstoria$166K
- Stephen NelsonMedford$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.